Analysis of mortality structure showed the increased ratio of deaths from the CMVI in the general structure of mortality: in 2010--50%, in 2011--60%, and in 2012--66.7%.
In the secondary infection (reactivation of latent persistent infection), risks of a fetal infection and the development of severe forms of CMVI are much lower and do not exceed 2%.
Antibodies CMV-IgG always show the persistence of the virus in all stages: in the acute phase, in the period of activation, and out of activation CMVI; there's only one difference in the avidity of antibodies.
According to the infectious morbidity the frequency of "morbidity" of CMVI is 4.61, and the frequency of "infection" of CMV is 52.5, in general, 57.2 per 1,000 children in the first year of life.
According to literature, the incidence rate of CMVI in Russia in 2003 among children under one year of age consisted of 11.58 per 100 thousand; 1-2 years--1.01; 3-5 years--0.44 per 100 thousand.
23 on December 12, 2013, are not always considered by the neonatologists and paediatricians for the diagnosis of CMVI both in hospital and in primary health care.
The proportion of mortality from CMVI in the general mortality rate amounted in 2010, to 50%; in 2011, to 60%; and in 2012, to 66.7%.